Lee Financial Co increased its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 100.0% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,756 shares of the company’s stock after acquiring an additional 878 shares during the quarter. Lee Financial Co’s holdings in Henry Schein were worth $144,000 as of its most recent filing with the SEC.
Other large investors have also added to or reduced their stakes in the company. Eads & Heald Investment Counsel increased its holdings in Henry Schein by 0.5% in the 2nd quarter. Eads & Heald Investment Counsel now owns 1,497 shares of the company’s stock valued at $274,000 after buying an additional 8 shares during the period. Intrust Bank NA increased its holdings in Henry Schein by 1.1% in the 2nd quarter. Intrust Bank NA now owns 1,219 shares of the company’s stock valued at $223,000 after buying an additional 13 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its holdings in Henry Schein by 0.3% in the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 5,894 shares of the company’s stock valued at $1,079,000 after buying an additional 19 shares during the period. YorkBridge Wealth Partners LLC increased its holdings in Henry Schein by 5.2% in the 2nd quarter. YorkBridge Wealth Partners LLC now owns 570 shares of the company’s stock valued at $104,000 after buying an additional 28 shares during the period. Finally, Sawtooth Solutions LLC increased its holdings in Henry Schein by 2.4% in the 2nd quarter. Sawtooth Solutions LLC now owns 1,347 shares of the company’s stock valued at $247,000 after buying an additional 32 shares during the period. 53.07% of the stock is currently owned by institutional investors and hedge funds.
Several equities research analysts recently issued reports on HSIC shares. Jefferies Group LLC reaffirmed a “hold” rating and set a $88.50 price target on shares of Henry Schein in a report on Friday, July 21st. BidaskClub lowered shares of Henry Schein from a “hold” rating to a “sell” rating in a report on Wednesday, August 2nd. Northcoast Research raised shares of Henry Schein from a “neutral” rating to a “buy” rating and set a $109.00 price target on the stock in a report on Monday, August 7th. Zacks Investment Research lowered shares of Henry Schein from a “buy” rating to a “hold” rating in a report on Wednesday, August 9th. Finally, Credit Suisse Group reaffirmed a “hold” rating and set a $87.50 price target on shares of Henry Schein in a report on Tuesday, August 29th. Two research analysts have rated the stock with a sell rating, eight have given a hold rating and seven have assigned a buy rating to the stock. Henry Schein has a consensus rating of “Hold” and an average target price of $89.88.
In related news, SVP Paul Rose sold 2,126 shares of the business’s stock in a transaction dated Wednesday, September 6th. The shares were sold at an average price of $172.51, for a total value of $366,756.26. Following the transaction, the senior vice president now directly owns 17,841 shares of the company’s stock, valued at approximately $3,077,750.91. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 1.19% of the company’s stock.
Shares of Henry Schein, Inc. (NASDAQ:HSIC) traded down $0.55 during mid-day trading on Tuesday, reaching $66.50. 3,873,200 shares of the company’s stock were exchanged, compared to its average volume of 1,118,817. The company has a market cap of $10,523.79, a price-to-earnings ratio of 18.81, a PEG ratio of 1.89 and a beta of 1.03. The company has a quick ratio of 0.86, a current ratio of 1.55 and a debt-to-equity ratio of 0.30. Henry Schein, Inc. has a fifty-two week low of $65.72 and a fifty-two week high of $93.50.
Henry Schein (NASDAQ:HSIC) last posted its earnings results on Monday, November 6th. The company reported $0.87 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.90 by ($0.03). Henry Schein had a return on equity of 19.71% and a net margin of 4.52%. The firm had revenue of $3.16 billion during the quarter, compared to the consensus estimate of $3.05 billion. During the same quarter in the previous year, the company earned $0.84 EPS. The business’s revenue was up 10.3% compared to the same quarter last year. research analysts anticipate that Henry Schein, Inc. will post 3.6 EPS for the current year.
Henry Schein announced that its Board of Directors has initiated a share repurchase program on Monday, September 18th that permits the company to repurchase $400.00 million in outstanding shares. This repurchase authorization permits the company to purchase up to 6.3% of its shares through open market purchases. Shares repurchase programs are usually an indication that the company’s management believes its stock is undervalued.
About Henry Schein
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.